0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA
Editorial  | 
Optimal Antiviral Prophylaxis Against Hepatitis B Reactivation in Patients Receiving Rituximab-Based Chemotherapy for Lymphoma
Jeremy S. Abramson, MD; Raymond T. Chung, MD
JAMA
Original Investigation  | 
Entecavir vs Lamivudine for Prevention of Hepatitis B Virus Reactivation Among Patients With Untreated Diffuse Large B-Cell Lymphoma Receiving R-CHOP Chemotherapy:  A Randomized Clinical Trial
He Huang, MD; Xueying Li, MD; Jun Zhu, MD, PhD; et al.
JAMA
Review  | 
Chronic Lymphocytic Leukemia:  A Clinical Review
Chadi Nabhan, MD; Steven T. Rosen, MD
JAMA Internal Medicine
Viewpoint  | 
The Withdrawal of Drugs for Commercial Reasons:  The Incomplete Story of Tositumomab
Vinay Prasad, MD